Abstract:OBJECTIVE: To identify novel functional genetic variants that influence disease risk and brain gene expression in late-onset Alzheimer's disease (LOAD) and progressive supranuclear palsy (PSP) by "Next-generation RNA-sequencing (RNA-seq)". BACKGROUND: We previously determined by microarray expression studies that variants at LOAD and PSP GWAS loci associate with brain expression levels of nearby genes. Next-generation RNA-seq can provide detailed information on transcriptional changes at a greater dynamic range than microarray approach. We performed RNA-seq in the temporal cortex tissue of ~100 LOAD and ~100 PSP subjects. Our first aim is to assess the LOAD and PSP GWAS risk loci for association with RNA-seq gene and exon levels. Our second aim is to assess the influence on transcriptional regulation of all variants that are detected by RNA-seq. DESIGN/METHODS: Library preparations and RNA-seq as paired-end 51 base pair runs on Illumina HiSeq2000 were carried out at the Mayo Clinic Advanced Genomic Technology Center (AGTC). Data analysis including read alignments, tabulation of detected genes and exons and their levels was completed utilizing the infrastructure and analytic pipelines established at the Mayo Bioinformatics Core (BIC). Gene expression levels were tested for association with cis variants (+/- 1Mb) and all tests were adjusted for relevant biological and technical covariates. RESULTS: For cis-eQTL analysis, 4,799,008 gene-SNP pairs were considered. False discovery rates (FDRs) were calculated according to Benjamini and Hochberg procedure to account for multiple hypothesis-testing correction. 1751 and 700 cis-eQTLs were detected at FDR<=5%, in LOAD and PSP brains, respectively with 421 common cis-eQTLs. At FDR <=10%, 2371 LOAD and 1305 PSP cis-eQTLs were detected with 541 common results. CONCLUSIONS: The cis-eQTLs identified in this RNA-seq data will be utilized to dissect the previously reported microarray expression associations and to identify novel cis-eQTL that also confer LOAD and PSP risk. Study Supported by: R01 AG032990, P50 AG016574, CurePSP Foundation, Mayo GHR Grant.

Genetics of cell-type-specific post-transcriptional gene regulation during human neurogenesis

Genetic regulation of cell type–specific chromatin accessibility shapes brain disease etiology

Single-Nucleus Atlas of Cell-Type Specific Genetic Regulation in the Human Brain

Cross-ancestry, cell-type-informed atlas of gene, isoform, and splicing regulation in the developing human brain

Genetic regulation of lncRNA expression in the whole human brain

Cell subtype-specific effects of genetic variation in the Alzheimer's disease brain

Spatiotemporal and Genetic Regulation of A-to-I Editing Throughout Human Brain Development.

cis-Regulatory Chromatin Contacts in Neural Cells Reveal Contributions of Genetic Variants to Complex Neurological Disorders

Expression quantitative trait loci in the developing human brain and their enrichment in neuropsychiatric disorders

Genetic regulation of microRNAs in the older adult brain and their contribution to neuropsychiatric conditions

Single-cell genomics and regulatory networks for 388 human brains

Allele-specific open chromatin in human iPSC neurons elucidates functional disease variants

Transcriptional programs regulating neuronal differentiation are disrupted in DLG2 knockout human embryonic stem cells and enriched for schizophrenia and related disorders risk variants

Developmental and genetic regulation of the human cortex transcriptome illuminate schizophrenia pathogenesis

Integrative Single-Cell Transcriptomics Reveals Molecular Networks Defining Neuronal Maturation During Postnatal Neurogenesis.

Regulation of alternative splicing and polyadenylation in neurons

Allele-specific transcription factor binding across human brain regions offers mechanistic insight into eQTLs

Expression QTL Studies in LOAD and PSP Brains by Next-Generation RNA Sequencing (I5-1.009)

Mapping cis -regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes

Neuronal and Glial 3D Chromatin Architecture Informs the Cellular Etiology of Brain Disorders

Developmental isoform diversity in the human neocortex informs neuropsychiatric risk mechanisms